Get Adobe Flash player


Authors: Loboda A.M. , Markevich V.E.

Pages: 64-71



The article is devoted to the study a diagnostic value of early markers of CNS (neuron specific enolase (NSE)) and kidney injury (cystatin C) in neonates undergoing asphyxia.

The study involved 75 full-term neonates with kidney disturbance: 45 children undergone severe asphyxia, and 30 children with moderate asphyxia. Comparison group consisted of 20 healthy children. Serum concentration of NSE and cystatin C measured on 1–2nd, 7–8th and 25–30th days of life by ELISA.

A significant level of NSE (above 29.5 ng/ml) is the early confirmation of the diagnosis of asphyxia. NSE content, which is above 56.2 ng/ml (1–2th days of life), is critical to predict the renal dysfunction development.

Increased cystatin C level after birth is an early and universal feature of hypoxic damage of the kidneys, as its serum level increases rapidly and reliably even at moderate asphyxia. The degree of kidney damage, depending on the severity of the asphyxia can be determined by the serum cystatin C level from the end of the early neonatal period. Detection of high concentrations of neurospecific proteins in serum at the late neonatal period requires monitoring of serum cystatin C.

Key words: asphyxia, neuron specific enolase, cystatin C, kidney, newborn.

               * This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text



  1. ShabalovNP, LiubimenkoVA, PalchikAB, YaroslavskiiVK. Asfiksiia novorozhdennykh [Neonatal asphyxia]. Moscow: MEDpress-inform Publ., 2003, 368 p.
  2. Morales P, Bustamante D, Espina-Marchant P, Neira-Pena T, Gutiérrez-Hernández MA, Allende-Castro C, et al.Pathophysiology of perinatal asphyxia: can we predict and improve individual230.
  3. de Haan M, Wyatt JS, Roth S, Vargha-Khadem F, Gadian D, Mishkin M. Brain and cognitivebehaviouraldevelopment after asphyxia at term birth. DEV SCI. 2006;9(4):350–358.
  4. Palsdottir K, Dagbjartsson A, Thorkelsson T, Hardardottir H. Birthasphyxiaandhypoxicischemicencephalopathy,incidenceandrisk
  5. KurinczukJJ, White-KoningM, BadawiN. Epidemiologyneonatalencephalopathyandhypoxic-ischaemicencephalopathy. EarlyHum. Dev. 2010;86:329–3
  6. VolodinNN, RogatkinSO. [Modernapproachestothe complextherapyprenatalinjuriesthecentralnervoussysteminnewborns]. Farmateka. 2004;1(80):72–82.
  7. AmericanCollegeObstetriciansandGynecologists; American Academy of Pediatrics. Neonatal encephalopathy and cerebral palsy: defining the pathogenesis and pathophysiology. Washington, DC: the American College of Obstetricians and Gynecologists. 2003, pp. 1
  8. Shah P, Riphagen S,Beyene J, Perlman M. Multiorgandysfunctionininfantswithpost-asphyxialhypoxic-ischaemicencephalopathy. Child. Fetal. Neonatal. 2004;89:152
  9. Blennow M, Savman K, Ilves P, Thoresen M, Rosengren
  10. Nagdyman N, Komen W, Ko HK, Muller C, Obladen M. Early biochemical indicators of hypoxic-ischemic encephalopathy after birth asphyxia. Pediatr Res. 2001;49(4):502
  11. Markevych VE, Petrashenko VO. [Diagnostic markers of perinatal hypoxic and ischemic injury of the central nervous system in premature newborns]. Perynatologiia i pediatriia. 2013;1(53):18–23.
  12. Gupta BD, Sharma P, Bagla J, Parakh M,Soni JP. RenalFailureinAsphyxiatedNeonates. IndianPediatrics. 2005;42:928–934.
  13. AndreoliSP. Acuterenalfailureinthenewborn. Semin. Perinatol. 2004;8:112–123.
  14. Lisowska-Myjak B. SerumandurinarybiomarkersacutekidneyBloodPurif. 2010;29:357–365.
  15. Zaitsev VM, Lifliandskii VG, Marinkin VI. Prikladnaia meditsinskaia statistika [Applied medical statistics]. Saint Petersburg: Foliant Publ., 2003, 432 p.
  16. Nebylitsova OV, editor. Laboratornyi spravochnik “SINEVO” [“SINEVO” Laboratory manual]. Kyiv: Doctor Media Publ.,2013, 644 p.
  17. Velkov VV. [Cystatin C: the new opportunities and new goals for laboratory diagnostics (Part 1)]. Kliniko-laboratornyi konsilium. 2010;5(36):23–31.
  18. Tkachiuk VA., editor. Klinicheskaia biokhimia: uchebnoe posobie [Clinical biochemistry: textbook. 3rd.]. Moscow: GEOTAR Media Publ., 2008, 454 p.
  19. Pokhylko VI. [Clinical and predictive value of estimation the level of neuron-specific enolase acting as a marker to determine severity of hypoxic central nervous system in premature newborns].WorldMedicineandBiology. 2008;4:93–96.
  20. Celtik C,Acunaş B,Oner N,Pala O. Neuron-specific enolaseas a marker of the severity and outcome of hypoxic ischemic encephalopathy. Brain Dev.2004;26(6):398–402.
  21. Massaro AN, Chang T, Kadom N, Tsuchida T, Scafidi J, Glass P, et al. Biomarkers of brain injury in neonatal encephalopathy treated with hypothermia.J. Pediatr.2012;161(3):434–440. doi: 10.1016/j.jpeds.2012.02.047